These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 26887853)
1. Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis. Fagarasanu A; Alotaibi GS; Hrimiuc R; Lee AY; Wu C Ann Surg Oncol; 2016 May; 23(5):1422-30. PubMed ID: 26887853 [TBL] [Abstract][Full Text] [Related]
2. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321 [TBL] [Abstract][Full Text] [Related]
3. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Rasmussen MS; Jørgensen LN; Wille-Jørgensen P Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234 [TBL] [Abstract][Full Text] [Related]
4. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777 [TBL] [Abstract][Full Text] [Related]
5. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366 [TBL] [Abstract][Full Text] [Related]
6. Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery. Carrier M; Altman AD; Blais N; Diamantouros A; McLeod D; Moodley U; Nguyen C; Young S; Schwenter F Am J Surg; 2019 Sep; 218(3):537-550. PubMed ID: 30595331 [TBL] [Abstract][Full Text] [Related]
7. Direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: a systematic review and meta-analysis. Zhou H; Ye LL; Zhou JT; Ma FX; Ma JJ; Zhang JH Surg Endosc; 2024 Mar; 38(3):1131-1138. PubMed ID: 38267639 [TBL] [Abstract][Full Text] [Related]
8. Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature. Knoll W; Fergusson N; Ivankovic V; Wang TF; Caiano L; Auer R; Carrier M Thromb Res; 2021 Aug; 204():114-122. PubMed ID: 34175749 [TBL] [Abstract][Full Text] [Related]
9. Extended versus conventional thromboprophylaxis after major abdominal and pelvic surgery: Systematic review and meta-analysis of randomized clinical trials. Rausa E; Kelly ME; Asti E; Aiolfi A; Bonitta G; Winter DC; Bonavina L Surgery; 2018 Dec; 164(6):1234-1240. PubMed ID: 30190110 [TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161 [TBL] [Abstract][Full Text] [Related]
11. Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer: A Systematic Review and Meta-analysis. Guo Q; Huang B; Zhao J; Ma Y; Yuan D; Yang Y; Du X Ann Surg; 2017 Jun; 265(6):1087-1093. PubMed ID: 27849664 [TBL] [Abstract][Full Text] [Related]
12. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. Huo MH; Muntz J Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383 [TBL] [Abstract][Full Text] [Related]
14. Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer. Wang Y; Wang M; Ni Y; Liang Z Hematology; 2020 Dec; 25(1):63-70. PubMed ID: 31984870 [No Abstract] [Full Text] [Related]